Marvin & Palmer Associates’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-33,413
Closed -$10.1M 31
2023
Q2
$10.1M Sell
33,413
-515
-2% -$143K 4.57% 8
2023
Q1
$8.95M Buy
+33,928
New +$8.62M 4.51% 13
2021
Q4
Sell
-43,261
Closed -$10.5M 27
2021
Q3
$10.5M Sell
43,261
-1,384
-3% -$338K 4.26% 12
2021
Q2
$9.23M Buy
+44,645
New +$9.1M 3.77% 14

Other funds holding HCA

Marvin & Palmer Associates's HCA Position: Q3 2023 in Review

Marvin & Palmer Associates sold out of HCA Healthcare (HCA) in Q3 2023, closing a stake of 33,413 shares — an estimated $10.1M sold.

Marvin & Palmer Associates first reported a position in HCA in Q2 2021 and held it in 4 quarters. The position peaked at $10.5M in Q3 2021. 1,000 funds tracked by Wall St. Rank hold HCA as of Q3 2023.

  • Marvin & Palmer Associates reported no remaining HCA Healthcare position as of Q3 2023 after selling out during the quarter.
  • Marvin & Palmer Associates sold 33,413 HCA Healthcare shares in Q3 2023, an estimated $10.1M.
  • Marvin & Palmer Associates first reported a position in HCA Healthcare in Q2 2021 and held it in 4 quarters.
  • Marvin & Palmer Associates's HCA Healthcare position peaked at $10.5M in Q3 2021.
  • 1,000 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2023.

Based on Marvin & Palmer Associates's 13F filing for Q3 2023, filed 13 Nov 2023.